Insights On Solid Dose Manufacturing

31. The Importance Of Polymorph Screenings 5/6/2026

    Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.

32. Low-Bioburden Powders For Terminal Sterilisation 2/24/2026

    Low‑bioburden powders for reconstitution demand strict microbial control, advanced formulation, and specialised manufacturing, making CDMO expertise vital for modern biopharma.

33. Exploring The Future Of Tablet Compression Across Emerging Industries 11/18/2025

    Many growing industries face universal tablet compression challenges, demanding better tooling, tighter process control, and more integrated data to ensure product consistency and reliable scale-up.

34. Blending And Simulation: A Beginner's Guide 2/26/2025

    This beginner-friendly webinar reveals essential steps to understand mixing, reduce segregation, enhance efficiency, and improve product quality with granular materials.

35. Tablet And Capsule Inspection: Detecting Defects Before They Ship 8/3/2026

    Inline X-ray inspection identifies density variations and foreign contaminants in solid dose products to prevent costly recalls and ensure strict quality compliance.

36. Engineering Challenges Of Designing Pharmaceutical Isolators 3/27/2025

    Designing pharmaceutical isolators requires navigating complex engineering hurdles, from ensuring chemical compatibility to optimizing airflow and pressure. Explore the critical considerations that guarantee drug manufacturing safety and efficiency.

37. Pharmaceutical X-Ray Counts Capsules And Pills 8/15/2025

    See how advanced x-ray inspection technology verifies correct pill count, identifies broken capsules, and detects foreign contaminants in pharmaceutical sachet packets.

38. Overcoming The Obstacles Of Spray-Dried Dispersion Scale-Up 9/9/2026

    SDD scale-up introduces scale-dependent risks that threaten bioavailability, stability, and manufacturability. This white paper details a model-based framework for managing those risks from early feasibility through commercial production.

39. 5 Hidden Risks In Early-Phase OSD Formulation Development 8/31/2026

    Early formulation decisions in OSD development carry risks that may not surface until later stages, when the cost of course correction is significantly higher.

40. GLP-1 OSD Chemical Synthesis Workflow 6/29/2026

    Enhance containment and process reliability in oral GLP-1 synthesis. Discover how integrated single-use assemblies and automated fluidics safeguard chemical purity during scale-up.